Cargando…
Paradigm shift for defining the resectability of pancreatic cancer
Supported by the expanding indications for neoadjuvant therapy (NAT) for advanced pancreatic cancer (PC), the concept of resectability has evolved from being mostly based on the anatomical tumor extent to considering the biological and conditional factors relevant to prognosis. Therefore, it is more...
Autores principales: | Kang, Mee Joo, Kim, Sun-Whe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Hepato-Biliary-Pancreatic Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639311/ https://www.ncbi.nlm.nih.gov/pubmed/34845115 http://dx.doi.org/10.14701/ahbps.2021.25.4.451 |
Ejemplares similares
-
En bloc proximal peri-mesenteric clearance for pancreatic head cancer surgery
por: Kang, Mee Joo, et al.
Publicado: (2020) -
Current status and perspectives of the future of pancreatic surgery: Establishment of evidence by integration of “art” and “science”
por: Kang, Mee Joo, et al.
Publicado: (2021) -
Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
por: Chawla, Akhil, et al.
Publicado: (2019) -
Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan
por: Furuse, Junji
Publicado: (2019) -
Cancer cells with p53 deletion detected by fluorescent in situ hybridization in peritoneal drainage fluid is correlated with early peritoneal seeding in resectable pancreatic cancer
por: Kang, Mee Joo, et al.
Publicado: (2013)